Old Web
English
Sign In
Acemap
>
authorDetail
>
Haley Gittleman
Haley Gittleman
Food and Drug Administration
Internal medicine
pooled analysis
Medicine
Oncology
Renal cell carcinoma
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
An FDA-pooled analysis of frontline combination treatment benefits by risk groups in metastatic renal cell carcinoma (mRCC).
2021
Journal of Clinical Oncology
Daniel Lee
Haley Gittleman
Chana Weinstock
Daniel L. Suzman
Erik Bloomquist
Sundeep Agrawal
Michael Holman Brave
Jamie Renee Brewer
Harpreet Singh
Shenghui Tang
Richard Pazdur
Julia A. Beaver
Amna Ibrahim
Laleh Amiri-Kordestani
Show All
Source
Cite
Save
Citations (1)
Survival benefit of nephrectomy prior to immunotherapy-based combinations in patients with metastatic renal cell carcinoma: An FDA pooled analysis.
2021
Journal of Clinical Oncology
Jaleh Fallah
Haley Gittleman
Chana Weinstock
Erik Bloomquist
Elaine Chang
Daniel L. Suzman
Sundeep Agrawal
Amna Ibrahim
Shenghui Tang
Richard Pazdur
Julia A. Beaver
Laleh Amiri-Kordestani
Show All
Source
Cite
Save
Citations (0)
1
map